APA

Tagliaferri P., Barile C., Caraglia M., Guarrasi R., Morelli D., Ricciardi B., Martignetti A., Librera M. T., Matano E., Della Vecchia A., Catalano G., Famiani M., Palmieri G., Correale P. & Bianco A. R. (19980306). Daily low-dose subcutaneous recombinant interleukin-2 by alternate weekly administration: antitumor activity and immunomodulatory effects. : American journal of clinical oncology.

Chicago

Tagliaferri P, Barile C, Caraglia M, Guarrasi R, Morelli D, Ricciardi B, Martignetti A, Librera M T, Matano E, Della Vecchia A, Catalano G, Famiani M, Palmieri G, Correale P and Bianco A R. 19980306. Daily low-dose subcutaneous recombinant interleukin-2 by alternate weekly administration: antitumor activity and immunomodulatory effects. : American journal of clinical oncology.

Harvard

Tagliaferri P., Barile C., Caraglia M., Guarrasi R., Morelli D., Ricciardi B., Martignetti A., Librera M. T., Matano E., Della Vecchia A., Catalano G., Famiani M., Palmieri G., Correale P. and Bianco A. R. (19980306). Daily low-dose subcutaneous recombinant interleukin-2 by alternate weekly administration: antitumor activity and immunomodulatory effects. : American journal of clinical oncology.

MLA

Tagliaferri P, Barile C, Caraglia M, Guarrasi R, Morelli D, Ricciardi B, Martignetti A, Librera M T, Matano E, Della Vecchia A, Catalano G, Famiani M, Palmieri G, Correale P and Bianco A R. Daily low-dose subcutaneous recombinant interleukin-2 by alternate weekly administration: antitumor activity and immunomodulatory effects. : American journal of clinical oncology. 19980306.